Global Cancer Targeted Drug Market Research Report 2017

August 2017 | 119 pages | ID: G3B3A19543CEN
QYResearch

Abstracts

In this report, the global Cancer Targeted Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cancer Targeted Drug in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Cancer Targeted Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Roche
• Eli Lilly
• Celgene
• Sanofi
• eisai
• Sumitomo Dainippon Pharma
• Merck
• Seattle Genetics
• Takeda
• Haosoh Pharma
• Novartis
• Pfizer

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tablet
• Injection
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Cancer Targeted Drug for each application, including

• Breast?Cancer
• Blood Cancer
• Prostate?Cancer
• Respiratory/Lung?Cancer
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Cancer Targeted Drug Market Research Report 2017

1 CANCER TARGETED DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Targeted Drug
1.2 Cancer Targeted Drug Segment by Type (Product Category)
  1.2.1 Global Cancer Targeted Drug Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
  1.2.2 Global Cancer Targeted Drug Production Market Share by Type (Product Category) in 2016
  1.2.3 Tablet
  1.2.4 Injection
  1.2.5 Other
1.3 Global Cancer Targeted Drug Segment by Application
  1.3.1 Cancer Targeted Drug Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Breast?Cancer
  1.3.3 Blood Cancer
  1.3.4 Prostate?Cancer
  1.3.5 Respiratory/Lung?Cancer
  1.3.6 Other
1.4 Global Cancer Targeted Drug Market by Region (2012-2022)
  1.4.1 Global Cancer Targeted Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Cancer Targeted Drug (2012-2022)
  1.5.1 Global Cancer Targeted Drug Revenue Status and Outlook (2012-2022)
  1.5.2 Global Cancer Targeted Drug Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL CANCER TARGETED DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Cancer Targeted Drug Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Cancer Targeted Drug Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Cancer Targeted Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Cancer Targeted Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Cancer Targeted Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Cancer Targeted Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Cancer Targeted Drug Market Competitive Situation and Trends
  2.5.1 Cancer Targeted Drug Market Concentration Rate
  2.5.2 Cancer Targeted Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL CANCER TARGETED DRUG CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Cancer Targeted Drug Capacity and Market Share by Region (2012-2017)
3.2 Global Cancer Targeted Drug Production and Market Share by Region (2012-2017)
3.3 Global Cancer Targeted Drug Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL CANCER TARGETED DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Cancer Targeted Drug Consumption by Region (2012-2017)
4.2 North America Cancer Targeted Drug Production, Consumption, Export, Import (2012-2017)
4.3 Europe Cancer Targeted Drug Production, Consumption, Export, Import (2012-2017)
4.4 China Cancer Targeted Drug Production, Consumption, Export, Import (2012-2017)
4.5 Japan Cancer Targeted Drug Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Cancer Targeted Drug Production, Consumption, Export, Import (2012-2017)
4.7 India Cancer Targeted Drug Production, Consumption, Export, Import (2012-2017)

5 GLOBAL CANCER TARGETED DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Cancer Targeted Drug Production and Market Share by Type (2012-2017)
5.2 Global Cancer Targeted Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Cancer Targeted Drug Price by Type (2012-2017)
5.4 Global Cancer Targeted Drug Production Growth by Type (2012-2017)

6 GLOBAL CANCER TARGETED DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Cancer Targeted Drug Consumption and Market Share by Application (2012-2017)
6.2 Global Cancer Targeted Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL CANCER TARGETED DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Roche
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Cancer Targeted Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Roche Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Eli Lilly
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Cancer Targeted Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Eli Lilly Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Celgene
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Cancer Targeted Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Celgene Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Sanofi
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Cancer Targeted Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Sanofi Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 eisai
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Cancer Targeted Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 eisai Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Sumitomo Dainippon Pharma
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Cancer Targeted Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Sumitomo Dainippon Pharma Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Merck
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Cancer Targeted Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Merck Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Seattle Genetics
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Cancer Targeted Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Seattle Genetics Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Takeda
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Cancer Targeted Drug Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Takeda Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Haosoh Pharma
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Cancer Targeted Drug Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Haosoh Pharma Cancer Targeted Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Novartis
7.12 Pfizer

8 CANCER TARGETED DRUG MANUFACTURING COST ANALYSIS

8.1 Cancer Targeted Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Targeted Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Cancer Targeted Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Targeted Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL CANCER TARGETED DRUG MARKET FORECAST (2017-2022)

12.1 Global Cancer Targeted Drug Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Cancer Targeted Drug Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Cancer Targeted Drug Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Cancer Targeted Drug Price and Trend Forecast (2017-2022)
12.2 Global Cancer Targeted Drug Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Cancer Targeted Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Cancer Targeted Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Cancer Targeted Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Cancer Targeted Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Cancer Targeted Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Cancer Targeted Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Cancer Targeted Drug Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Cancer Targeted Drug Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Targeted Drug
Figure Global Cancer Targeted Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Cancer Targeted Drug Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Tablet
Table Major Manufacturers of Tablet
Figure Product Picture of Injection
Table Major Manufacturers of Injection
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Cancer Targeted Drug Consumption (K Units) by Applications (2012-2022)
Figure Global Cancer Targeted Drug Consumption Market Share by Applications in 2016
Figure Breast?Cancer Examples
Table Key Downstream Customer in Breast?Cancer
Figure Blood Cancer Examples
Table Key Downstream Customer in Blood Cancer
Figure Prostate?Cancer Examples
Table Key Downstream Customer in Prostate?Cancer
Figure Respiratory/Lung?Cancer Examples
Table Key Downstream Customer in Respiratory/Lung?Cancer
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Cancer Targeted Drug Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Cancer Targeted Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Cancer Targeted Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Cancer Targeted Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Cancer Targeted Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Cancer Targeted Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Cancer Targeted Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Cancer Targeted Drug Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Cancer Targeted Drug Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Cancer Targeted Drug Major Players Product Capacity (K Units) (2012-2017)
Table Global Cancer Targeted Drug Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Cancer Targeted Drug Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Cancer Targeted Drug Capacity (K Units) of Key Manufacturers in 2016
Figure Global Cancer Targeted Drug Capacity (K Units) of Key Manufacturers in 2017
Figure Global Cancer Targeted Drug Major Players Product Production (K Units) (2012-2017)
Table Global Cancer Targeted Drug Production (K Units) of Key Manufacturers (2012-2017)
Table Global Cancer Targeted Drug Production Share by Manufacturers (2012-2017)
Figure 2016 Cancer Targeted Drug Production Share by Manufacturers
Figure 2017 Cancer Targeted Drug Production Share by Manufacturers
Figure Global Cancer Targeted Drug Major Players Product Revenue (Million USD) (2012-2017)
Table Global Cancer Targeted Drug Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Cancer Targeted Drug Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Cancer Targeted Drug Revenue Share by Manufacturers
Table 2017 Global Cancer Targeted Drug Revenue Share by Manufacturers
Table Global Market Cancer Targeted Drug Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Cancer Targeted Drug Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Cancer Targeted Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Targeted Drug Product Category
Figure Cancer Targeted Drug Market Share of Top 3 Manufacturers
Figure Cancer Targeted Drug Market Share of Top 5 Manufacturers
Table Global Cancer Targeted Drug Capacity (K Units) by Region (2012-2017)
Figure Global Cancer Targeted Drug Capacity Market Share by Region (2012-2017)
Figure Global Cancer Targeted Drug Capacity Market Share by Region (2012-2017)
Figure 2016 Global Cancer Targeted Drug Capacity Market Share by Region
Table Global Cancer Targeted Drug Production by Region (2012-2017)
Figure Global Cancer Targeted Drug Production (K Units) by Region (2012-2017)
Figure Global Cancer Targeted Drug Production Market Share by Region (2012-2017)
Figure 2016 Global Cancer Targeted Drug Production Market Share by Region
Table Global Cancer Targeted Drug Revenue (Million USD) by Region (2012-2017)
Table Global Cancer Targeted Drug Revenue Market Share by Region (2012-2017)
Figure Global Cancer Targeted Drug Revenue Market Share by Region (2012-2017)
Table 2016 Global Cancer Targeted Drug Revenue Market Share by Region
Figure Global Cancer Targeted Drug Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Cancer Targeted Drug Consumption (K Units) Market by Region (2012-2017)
Table Global Cancer Targeted Drug Consumption Market Share by Region (2012-2017)
Figure Global Cancer Targeted Drug Consumption Market Share by Region (2012-2017)
Figure 2016 Global Cancer Targeted Drug Consumption (K Units) Market Share by Region
Table North America Cancer Targeted Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Cancer Targeted Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Cancer Targeted Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Cancer Targeted Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Cancer Targeted Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Cancer Targeted Drug Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Cancer Targeted Drug Production (K Units) by Type (2012-2017)
Table Global Cancer Targeted Drug Production Share by Type (2012-2017)
Figure Production Market Share of Cancer Targeted Drug by Type (2012-2017)
Figure 2016 Production Market Share of Cancer Targeted Drug by Type
Table Global Cancer Targeted Drug Revenue (Million USD) by Type (2012-2017)
Table Global Cancer Targeted Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Cancer Targeted Drug by Type (2012-2017)
Figure 2016 Revenue Market Share of Cancer Targeted Drug by Type
Table Global Cancer Targeted Drug Price (USD/Unit) by Type (2012-2017)
Figure Global Cancer Targeted Drug Production Growth by Type (2012-2017)
Table Global Cancer Targeted Drug Consumption (K Units) by Application (2012-2017)
Table Global Cancer Targeted Drug Consumption Market Share by Application (2012-2017)
Figure Global Cancer Targeted Drug Consumption Market Share by Applications (2012-2017)
Figure Global Cancer Targeted Drug Consumption Market Share by Application in 2016
Table Global Cancer Targeted Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Cancer Targeted Drug Consumption Growth Rate by Application (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Cancer Targeted Drug Production Growth Rate (2012-2017)
Figure Roche Cancer Targeted Drug Production Market Share (2012-2017)
Figure Roche Cancer Targeted Drug Revenue Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Cancer Targeted Drug Production Growth Rate (2012-2017)
Figure Eli Lilly Cancer Targeted Drug Production Market Share (2012-2017)
Figure Eli Lilly Cancer Targeted Drug Revenue Market Share (2012-2017)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Cancer Targeted Drug Production Growth Rate (2012-2017)
Figure Celgene Cancer Targeted Drug Production Market Share (2012-2017)
Figure Celgene Cancer Targeted Drug Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Cancer Targeted Drug Production Growth Rate (2012-2017)
Figure Sanofi Cancer Targeted Drug Production Market Share (2012-2017)
Figure Sanofi Cancer Targeted Drug Revenue Market Share (2012-2017)
Table eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table eisai Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure eisai Cancer Targeted Drug Production Growth Rate (2012-2017)
Figure eisai Cancer Targeted Drug Production Market Share (2012-2017)
Figure eisai Cancer Targeted Drug Revenue Market Share (2012-2017)
Table Sumitomo Dainippon Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sumitomo Dainippon Pharma Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sumitomo Dainippon Pharma Cancer Targeted Drug Production Growth Rate (2012-2017)
Figure Sumitomo Dainippon Pharma Cancer Targeted Drug Production Market Share (2012-2017)
Figure Sumitomo Dainippon Pharma Cancer Targeted Drug Revenue Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Cancer Targeted Drug Production Growth Rate (2012-2017)
Figure Merck Cancer Targeted Drug Production Market Share (2012-2017)
Figure Merck Cancer Targeted Drug Revenue Market Share (2012-2017)
Table Seattle Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seattle Genetics Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Seattle Genetics Cancer Targeted Drug Production Growth Rate (2012-2017)
Figure Seattle Genetics Cancer Targeted Drug Production Market Share (2012-2017)
Figure Seattle Genetics Cancer Targeted Drug Revenue Market Share (2012-2017)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Cancer Targeted Drug Production Growth Rate (2012-2017)
Figure Takeda Cancer Targeted Drug Production Market Share (2012-2017)
Figure Takeda Cancer Targeted Drug Revenue Market Share (2012-2017)
Table Haosoh Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Haosoh Pharma Cancer Targeted Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Haosoh Pharma Cancer Targeted Drug Production Growth Rate (2012-2017)
Figure Haosoh Pharma Cancer Targeted Drug Production Market Share (2012-2017)
Figure Haosoh Pharma Cancer Targeted Drug Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Targeted Drug
Figure Manufacturing Process Analysis of Cancer Targeted Drug
Figure Cancer Targeted Drug Industrial Chain Analysis
Table Raw Materials Sources of Cancer Targeted Drug Major Manufacturers in 2016
Table Major Buyers of Cancer Targeted Drug
Table Distributors/Traders List
Figure Global Cancer Targeted Drug Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Targeted Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Targeted Drug Price (Million USD) and Trend Forecast (2017-2022)
Table Global Cancer Targeted Drug Production (K Units) Forecast by Region (2017-2022)
Figure Global Cancer Targeted Drug Production Market Share Forecast by Region (2017-2022)
Table Global Cancer Targeted Drug Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Cancer Targeted Drug Consumption Market Share Forecast by Region (2017-2022)
Figure North America Cancer Targeted Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Cancer Targeted Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Cancer Targeted Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Cancer Targeted Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Cancer Targeted Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Cancer Targeted Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Cancer Targeted Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Cancer Targeted Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Cancer Targeted Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Cancer Targeted Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Targeted Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Cancer Targeted Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Cancer Targeted Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Targeted Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Cancer Targeted Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Cancer Targeted Drug Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Cancer Targeted Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Cancer Targeted Drug Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Cancer Targeted Drug Production (K Units) Forecast by Type (2017-2022)
Figure Global Cancer Targeted Drug Production (K Units) Forecast by Type (2017-2022)
Table Global Cancer Targeted Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Cancer Targeted Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Cancer Targeted Drug Price Forecast by Type (2017-2022)
Table Global Cancer Targeted Drug Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Cancer Targeted Drug Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source